Study reveals how patients' smoking history changes evolution of lung cancer
Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments.
Apr 20, 2023
0
30
Understanding the differences in the evolution of lung cancer between smokers and non-smokers could be the key to unlocking new treatments.
Apr 20, 2023
0
30
A key mechanism of cadmium-linked inflammation that increases severity and mortality of lung infections has been described, offering a promising therapeutic target to limit lung injury and death.
Apr 20, 2023
0
15
One of the newest types of cancer drugs, immunotherapies called immune checkpoint inhibitors, has transformed the treatment of lung cancer over the last decade—dramatically improving the survival of some patients with the ...
Apr 19, 2023
0
23
A scientific team that includes University of Montana biologist Mark Grimes recently used artificial intelligence to better understand how protein groups in lung cancer cells regulate cell division and metabolism.
Apr 19, 2023
0
2
Peter Szlosarek, Professor of Medical Oncology at Queen Mary's Barts Cancer Institute, presented his team's results from the ATOMIC-Meso clinical trial in partnership with Polaris Pharmaceuticals, Inc., at the American Association ...
Apr 18, 2023
0
15
Abnormal sleep patterns, like those of night-shift workers, disrupt the body's natural biological clock and have been linked to lung health issues. A new study by University of Rochester Medical Center (URMC) researchers ...
Apr 17, 2023
0
44
A new research paper was published on the cover of Aging entitled, "p21 facilitates chronic lung inflammation via epithelial and endothelial cells."
Apr 17, 2023
0
2
A new research perspective was published in Oncotarget entitled "Cancer prevention with rapamycin."
Apr 17, 2023
0
1
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone ...
Apr 16, 2023
0
4
The oncogenic activation of MYC, a critical gene in cancer progression, has the potential to identify lung cancer patients who may respond poorly to immunotherapy (ICB). This is the main conclusion of a study recently published ...
Apr 14, 2023
0
54